These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

737 related items for PubMed ID: 35730485

  • 1. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y, Wang B, Yan Y, Niu L.
    Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
    [Abstract] [Full Text] [Related]

  • 2. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R, Huang Z, Qian C, Wang M, Zheng Y, Jiang R, Yu C.
    Biochem Biophys Res Commun; 2020 Jun 11; 526(4):1005-1012. PubMed ID: 32307083
    [Abstract] [Full Text] [Related]

  • 3. Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer.
    Zhang X, Li F, Zhou Y, Mao F, Lin Y, Shen S, Li Y, Zhang S, Sun Q.
    Cell Death Dis; 2021 Jun 18; 12(7):627. PubMed ID: 34145213
    [Abstract] [Full Text] [Related]

  • 4. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
    Han C, Fu Y, Zeng N, Yin J, Li Q.
    Aging (Albany NY); 2020 Feb 17; 12(4):3594-3616. PubMed ID: 32074085
    [Abstract] [Full Text] [Related]

  • 5. CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-149-5p to Up-Regulate CTCF and CTNNB1 to Activate Wnt/β-Catenin Pathway.
    Zhu S, Sun J, Liu X, Shao H, Feng C, Wang Z, Zheng X, Wei S.
    Mol Cell Biol; 2022 Jun 16; 42(6):e0018821. PubMed ID: 35499320
    [Abstract] [Full Text] [Related]

  • 6. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
    Du C, Wang Y, Zhang Y, Zhang J, Zhang L, Li J.
    Cell Transplant; 2020 Jun 16; 29():963689720929983. PubMed ID: 32686982
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54.
    Liu B, Yao P, Xiao F, Guo J, Wu L, Yang Y.
    J Transl Med; 2021 Aug 05; 19(1):333. PubMed ID: 34353336
    [Abstract] [Full Text] [Related]

  • 9. Profiling of specific long non-coding RNA signatures identifies ST8SIA6-AS1 AS a novel target for breast cancer.
    Chen Z, Huang J, Feng Y, Li Z, Jiang Y.
    J Gene Med; 2021 Feb 05; 23(2):e3286. PubMed ID: 33037712
    [Abstract] [Full Text] [Related]

  • 10. Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis.
    Guo C, Zhang M, Jin X, Zhu C, Qian J, Tao M.
    Cell Biochem Funct; 2024 Jun 05; 42(4):e4020. PubMed ID: 38702967
    [Abstract] [Full Text] [Related]

  • 11. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression.
    Zhang X, Xu S, Hu C, Fang K, Zhou J, Guo Z, Zhu G, Li L.
    Biochem Biophys Res Commun; 2020 Dec 17; 533(4):1039-1047. PubMed ID: 33012505
    [Abstract] [Full Text] [Related]

  • 12. lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer.
    Yu H, Wu Y, Huang J, Li S.
    Anticancer Res; 2023 Dec 17; 43(12):5475-5484. PubMed ID: 38030196
    [Abstract] [Full Text] [Related]

  • 13. ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6.
    Li Y, Jiang A.
    Cancer Biol Ther; 2020 Jul 02; 21(7):647-655. PubMed ID: 32420798
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. LncRNA ST8SIA6-AS1 promotes colorectal cancer cell proliferation, migration and invasion by regulating the miR-5195/PCBP2 axis.
    Huang CM, Cao GY, Yang CX, Chen Y, Liu GD, Xu BW, Zhang X.
    Eur Rev Med Pharmacol Sci; 2020 Apr 02; 24(8):4203-4211. PubMed ID: 32373956
    [Abstract] [Full Text] [Related]

  • 20. LncRNA PSMA3-AS1 activates the progression of triple-negative breast cancer cells by blocking miR-186-5p-mediated PSME3 inhibition.
    Peng M, Yuan H.
    Cell Mol Biol (Noisy-le-grand); 2023 Dec 20; 69(14):81-87. PubMed ID: 38279473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.